Associations between alpha diversity and cancer patient outcomes have been found in the setting of patients receiving hematopoietic cell transplant29 or cervical cancer chemoradiation30 but not in anti-PD-1 recipients with metastatic melanoma16,18; thus, such associations may be treatment regimen specific. The gene discussed is PDCD1; the disease is cervical carcinoma.